Patents by Inventor Kevin A. Myers

Kevin A. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160257328
    Abstract: An apparatus to maneuver a load includes a set of uprights including a set of legs extending generally vertically upward and a set of arms extending from the legs in an adjustable manner. A set of rollers supports the legs to facilitate rolling of the apparatus over the ground. The load is suspendible within a space between the arms, and the uprights are adjustably movable in a direction toward one another to maneuver the load. The apparatus also may include a set of adjustable links extending between at least two uprights of the set of uprights, wherein the set of adjustable links aid in adjusting the uprights between angled and substantially upright positions. The apparatus may be a hoist for raising or lowering a hard top from a vehicle, wherein the apparatus straddles a vehicle hard top. A method is also disclosed and claimed.
    Type: Application
    Filed: March 3, 2016
    Publication date: September 8, 2016
    Inventor: Kevin Myers
  • Publication number: 20140200838
    Abstract: A water saving device including a housing and a processor disposed within the housing. The processor calculates a water volume expended over a period of time based on a predetermined volumetric flow rate and time. A sensor is disposed within the housing for sensing the presence of a user. The sensor is operably connected to the processor. The sensor generates a signal to cause the processor to begin calculating the water volume upon sensing the presence of a user. A display indicates the expended water volume and is operatively connected to the processor. The display shows a virtual water level which rises as time and water usage increases.
    Type: Application
    Filed: January 15, 2014
    Publication date: July 17, 2014
    Applicant: GREEN STARTS HERE, LLC
    Inventor: Kevin Myers
  • Patent number: 8619086
    Abstract: Three dimensional scenes may be managed between a central processing unit and a graphics processing unit using shared and unified graphics processing unit memory. A shared bus memory may be synchronized between the central processing unit and the graphics processing unit. The shared bus memory may be used for more often updated components and other memory may be used for less often updated components. In some embodiments, if the graphics processor and the central processor use a common processor instruction set architecture, data can be sent from the central processor to the graphics processor without serializing the data.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: December 31, 2013
    Assignee: Intel Corporation
    Inventors: Antony Arciuolo, Ian Lewis, Kevin Myers
  • Patent number: 8094152
    Abstract: One embodiment of the present invention sets forth a technique for performing dual depth peeling, which is useful for order-independent transparency blending. Multiple rendering passes are performed on a graphics scene. After each rendering pass, the front-most and back-most layer of pixels are peeled away by computing a reference window. In subsequent rendering passes, only pixels within the reference window survive depth sorting. In each subsequent rendering pass, the reference window is narrowed by the front most and back most surviving pixels. By performing depth peeling in two directions simultaneously, the number of rendering passes needed to generate a completed graphics image is reduced from L to 1+L/2, which results in improved rendering performance.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: January 10, 2012
    Assignee: NVIDIA Corporation
    Inventors: Kevin Myers, Louis Bavoil, Mehmet Cem Cebenoyan
  • Patent number: 8094151
    Abstract: One embodiment of the present invention sets forth a technique for performing dual depth peeling, which is useful for order-independent transparency blending. Multiple rendering passes are performed on a graphics scene. After each rendering pass, the front-most and back-most layer of pixels are peeled away by computing a reference window. In subsequent rendering passes, only pixels within the reference window survive depth sorting. In each subsequent rendering pass, the reference window is narrowed by the front most and back most surviving pixels. By performing depth peeling in two directions simultaneously, the number of rendering passes needed to generate a completed graphics image is reduced from L to 1+L/2, which results in improved rendering performance.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: January 10, 2012
    Assignee: NVIDIA Corporation
    Inventors: Kevin Myers, Louis Bavoil, Mehmet Cem Cebenoyan
  • Publication number: 20100277484
    Abstract: Three dimensional scenes may be managed between a central processing unit and a graphics processing unit using shared and unified graphics processing unit memory. A shared bus memory may be synchronized between the central processing unit and the graphics processing unit. The shared bus memory may be used for more often updated components and other memory may be used for less often updated components. In some embodiments, if the graphics processor and the central processor use a common processor instruction set architecture, data can be sent from the central processor to the graphics processor without serializing the data.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 4, 2010
    Inventors: Antony Arciuolo, Ian Lewis, Kevin Myers
  • Publication number: 20100277488
    Abstract: A rasterizer may use only triangle position information. In this way, it is not necessary to rasterize objects that end up being culled in screen space.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 4, 2010
    Inventors: Kevin Myers, Antony Arciuolo, Ian Lewis
  • Patent number: 7718627
    Abstract: A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: May 18, 2010
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Susan M. Kingsman, Christopher R. Bebbington, Fiona M. Ellard, Miles W. Carroll, Kevin A. Myers
  • Patent number: 7666669
    Abstract: The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: February 23, 2010
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Miles W. Carroll, Kevin A. Myers
  • Patent number: 7615612
    Abstract: The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
    Type: Grant
    Filed: March 15, 2007
    Date of Patent: November 10, 2009
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Miles W. Carroll, Kevin A. Myers
  • Patent number: 7601698
    Abstract: The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: October 13, 2009
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Miles W. Carroll, Kevin A. Myers
  • Patent number: 7514546
    Abstract: The use of an ScFv Ab (ScFv Ab) capable of recognizing a disease associated molecule (DAM) in the manufacture of a medicament for the prevention and/or treatment of a disease condition associated with a DAM is described. The ScFv Ab has therapeutic, diagnostic and prognostic applications.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: April 7, 2009
    Assignee: Oxford BioMedica (UK) Ltd.
    Inventors: Susan Mary Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Kevin A. Myers
  • Publication number: 20080279854
    Abstract: Canine and feline 5T4 polypeptide sequences and nucleotide sequences encoding them are provided. A vector system comprising a nucleic acid encoding 5T4 and a 5T4-specific agent are also provided.
    Type: Application
    Filed: July 7, 2008
    Publication date: November 13, 2008
    Applicant: OXFORD BIOMEDICA (UK) LIMITED
    Inventors: Kevin Myers, Noel Drury, Miles Carroll
  • Publication number: 20080274542
    Abstract: Canine and feline 5T4 polypeptide sequences and nucleotide sequences encoding them are provided. A vector system comprising a nucleic acid encoding 5T4 and a 5T4-specific agent are also provided.
    Type: Application
    Filed: July 8, 2008
    Publication date: November 6, 2008
    Applicant: OXFORD BIOMEDICA (UK) LIMITED
    Inventors: Kevin Myers, Noel Drury, Miles Carroll
  • Publication number: 20080175819
    Abstract: The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.
    Type: Application
    Filed: August 6, 2007
    Publication date: July 24, 2008
    Applicant: Oxford BioMedica (UK) Limited
    Inventors: Alan J. Kingsman, Christopher R. Bebbington, Miles W. Carroll, Fiona M. Ellard, Susan M. Kingsman, Kevin A. Myers
  • Patent number: 7402666
    Abstract: Canine and feline 5T4 polypeptide sequences and nucleotide sequences encoding them are provided. A vector system comprising a nucleic acid encoding 5T4 and a 5T4-specific agent are also provided.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: July 22, 2008
    Assignee: Oxford Biomedica (UK) Ltd.
    Inventors: Kevin Myers, Miles Carroll
  • Patent number: 7314198
    Abstract: An inflation valve for use with an inflatable emergency evacuation slide includes a thermally actuated gas relief valve having an exhaust port the effective size of which increases with increasing temperature. The exhaust port is metered by a valve member. The valve member position is controlled by a thermal actuator that lengthens with increasing temperature. At high ambient temperatures, the valve member moves to uncover the exhaust port thereby increasing the effective size of the port so that a large percentage of the inflation gas is vented. At low ambient temperatures the valve member moves to cover the exhaust port, thereby decreasing effective size of the exhaust port so that little or no inflation gas is vented.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: January 1, 2008
    Assignee: Goodrich Corporation
    Inventors: Kevin Myers, Andrew Clegg, Peter P. Seabase
  • Publication number: 20070298055
    Abstract: The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
    Type: Application
    Filed: March 15, 2007
    Publication date: December 27, 2007
    Applicant: Oxford BioMedica (UK) Limited
    Inventors: Miles Carroll, Kevin Myers
  • Publication number: 20070259400
    Abstract: The use of an ScFv Ab (ScFv Ab) capable of recognising a disease associated molecule (DAM) in the manufacture of a medicament for the prevention and/or treatment of a disease condition associated with a DAM is described. The ScFv Ab has therapeutic, diagnostic and prognostic applications.
    Type: Application
    Filed: April 26, 2006
    Publication date: November 8, 2007
    Applicant: Oxford BioMedica (UK) Limited
    Inventors: Alan Kingsman, Susan Kingsman, Christopher Bebbington, Miles Carrol, Fiona Ellard, Kevin Myers
  • Patent number: 7287727
    Abstract: An inflatable aircraft evacuation slide system includes a primary valve, a bust disk and a valve leakage trap operatively disposed between the primary valve and the burst disk. The valve leakage trap comprises a small exhaust vent opening into a flow restriction orifice in the gas path between the primary valve and the burst disk. In operation, when the aircraft emergency exit is opened in the armed condition, the primary valve opens and pressurizes the chamber until the burst disk ruptures allowing inflation gases to pass through the flow restriction orifice to inflate the inflatable evacuation slide. Because there is a substantial pressure drop across the flow restriction orifice, the presence of the valve leakage safety vent in the orifice does not result in significant loss of inflation gas needed for inflating the inflatable evacuation slide. In the event of leakage past the primary valve, however, the valve leakage trap safely vents the leakage pressure to the atmosphere.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: October 30, 2007
    Assignee: Goodrich Corporation
    Inventors: Kevin Myers, Richard B. Yori, Peter Seabase, Christopher J. Bock